1. Untargeted blood serum proteomics identifies novel proteins related to neurological recovery after human spinal cord injury
- Author
-
Daniel Garcia-Ovejero, Evelyn Beyerer, Orpheus Mach, Iris Leister, Martin Strowitzki, Christof Wutte, Doris Maier, John LK Kramer, Ludwig Aigner, Angel Arevalo-Martin, and Lukas Grassner
- Subjects
SERPINE1 ,RAGE ,Calumenin ,CD300 ,ARHGAP35 ,Defensin ,Medicine - Abstract
Abstract Background The discovery of new prognostic biomarkers following spinal cord injury (SCI) is a rapidly growing field that could help uncover the underlying pathological mechanisms of SCI and aid in the development of new therapies. To date, this search has largely focused on the initial days after the lesion. However, during the subacute stage of SCI (weeks to months after the injury), there remains potential for sensorimotor recovery, and numerous secondary events develop in various organs. Additionally, the confounding effects of early interventions after the injury are less likely to interfere with the results. Methods In this study, we conducted an untargeted proteomics analysis to identify biomarkers of recovery in blood serum samples during the subacute phase of SCI patients, comparing those with strong recovery to those with no recovery between 30 and 120 days. We analyzed the fraction of serum that is depleted of the most abundant proteins to unmask proteins that would otherwise go undetected. Linear models were used to identify peptides and proteins related to neurological recovery and we validated changes in some of these proteins using Enzyme-linked Immunosorbent Assay (ELISA). Results Our findings reveal that differences in subacute recovery after SCI (from 30 to 120 days) are associated with an enrichment in proteins involved in inflammation, coagulation, and lipid metabolism. Technical validation using commercial ELISAs further confirms that high levels of SERPINE1 and ARHGAP35 are associated with strong neurological recovery, while high levels of CD300a and DEFA1 are associated with a lack of recovery. Conclusions Our study identifies new candidates for biomarkers of neurological recovery and for novel therapeutic targets after SCI.
- Published
- 2024
- Full Text
- View/download PDF